2026-03-12 20:40:45
Avanos Medical Increases CEO's Long-Term Incentive Grant to $5.5 Million
Expected Stock impact: Slightly Positive
On March 6, 2026, Avanos Medical, Inc. announced an increase in the target value of the annual long-term incentive grant for CEO David C. Pacitti from $5 million to $5.5 million, effective for 2026. This adjustment reflects the company's commitment to leadership and performance incentives.
